Beijing QL Biopharmaceutical Co.,Ltd
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Beijing QL Biopharmaceutical Co.,Ltd
Chinese RNA Therapy Developers Extend Fundraising Streak Into December
In the latest venture capital and private equity funding deals in China, SanegeneBio, Argo Biopharma and Ausper Biopharma raised a combined $136m on the back of their early-stage small interfering RNA and antisense oligonucleotide assets.
Chinese Gene And Cell Therapy, mRNA Developers Raise More Funds In March
Roughly $130m was raised in eight biopharma financings in China over the past months that were backed by venture capital investors.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- QL Biopharmaceutical Australia Pty Ltd
- QL Biopharma
- BJ QL Biopharmaceutical Co. Ltd.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice